We have been working closely with the Nanomedicine Center for Protein Folding on pushing our lead compounds forward. They have gone from the test tube to the first round of testing beyond that (onto tissue) and we’re continuing to refine the compounds based on the results obtained so far. Also, FAH researcher Dr. Yu-Shan Lin has been awarded a BioX Postdoctoral Fellowship for her proposed work on Alzheimer’s Disease simulation.
